NDRG2 and breast cancer: Further analysis of samples from 211 breast cancer patients has revealed a positive correlation between high NDRG2 expression and worse outcome for patients with basal-like tumors, as well as favorable overall and relapse-free survival for patients with luminal A breast cancer, supporting the contention that NDRG2 is associated with aggressiveness and unfavorable outcomes in aggressive breast cancers [75].